Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2014
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8884029 Dye for photoelectric conversion device and photoelectric conversion device
11/11/2014US8884014 Method for purifying a fused pyrrolocarbazole derivative
11/11/2014US8884013 Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof
11/11/2014US8884010 Method for producing pyridazinone compounds and intermediate thereof
11/11/2014US8884006 Small-molecule inhibitors of Rac1 in metastatic breast cancer
11/11/2014US8883888 Diarylamine compounds, aging inhibitor, polymer composition, crosslinked rubber product and molded article of the crosslinked product, and method of producing diarylamine compound
11/11/2014US8883826 Alkynyl derivatives as modulators of metabotropic glutamate receptors
11/11/2014US8883810 Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
11/11/2014US8883798 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin E2, method of production thereof and use thereof
11/11/2014US8883797 Metalloenzyme inhibitor compounds
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883788 Fused heterocyclic ring compound
11/11/2014US8883785 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/11/2014US8883135 Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor
11/06/2014US20140330010 Phenylpyrrole derivative
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/06/2014US20140329873 Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid
11/06/2014US20140329823 Dimeric IAP Inhibitors
11/06/2014US20140329816 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329815 Inhibitors of c-fms kinase
11/06/2014US20140329812 Aryl triazole compounds with antitumoural activity
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
11/06/2014US20140329795 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
11/06/2014US20140329331 Novel cyanine derivatives having meso-reactive functional group at polymethine chain and preparation method thereof
11/06/2014US20140328805 Biheteroaryl compounds and uses thereof
11/04/2014US8877968 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/04/2014US8877942 2,2′-disubstituted dipyrrin compounds, synthesis thereof and methods of use thereof
11/04/2014US8877939 Copper-catalysed ligation of azides and acetylenes
11/04/2014US8877924 Benzyl substituted triazine derivatives and their therapeutical applications
11/04/2014US8877797 Methods for treating Parkinson's disease using pro-neurogenic compounds
11/04/2014US8877794 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
11/04/2014US8877766 Neuroprotective multifunctional antioxidants and their monofunctional analogs
11/04/2014US8877761 N-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as PKC kinase inhibitors
11/04/2014US8877759 Aminopyrazines as ATR kinase inhibitors
11/04/2014US8877757 Pyrazine derivatives and use as PI3K inhibitors
11/04/2014US8877753 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
11/04/2014US8877747 Indenone derivative and pharmaceutical composition comprising same
11/04/2014US8877709 Reversible pegylated drugs
11/04/2014US8877707 Inhibitors of HCV NS5A
11/04/2014US8877352 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
11/04/2014US8877315 Indolium compound and optical recording material containing the same
11/04/2014US8877171 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
10/2014
10/30/2014US20140323729 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
10/30/2014US20140323725 Processes of synthesizing dihydropyridophthalazinone derivatives
10/30/2014US20140323535 5-oxo-ete receptor antagonist compounds
10/30/2014US20140323499 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x2/3 antagonists
10/30/2014US20140323488 Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
10/30/2014US20140323485 N-Substituted Heterocyclyl Carboxamides
10/30/2014US20140323484 Pharmaceutically Active Pyrazine Derivatives
10/30/2014US20140323470 Kinase inhibitors
10/30/2014US20140323465 Hcv protease inhibitors and uses thereof
10/30/2014US20140323464 Kinase inhibitors
10/30/2014US20140323463 Pyrazinecarboxamide compound
10/30/2014US20140323458 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections
10/30/2014US20140323448 sGC STIMULATORS
10/30/2014US20140323418 Selective kinase inhibitors
10/30/2014US20140322247 Cell proliferation inhibitors and conjugates thereof
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871946 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
10/28/2014US8871940 Unsymmetrical bisazides for chemoselective sequential ligation
10/28/2014US8871930 Preparation method of alpha-imatinib mesylate
10/28/2014US8871788 Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
10/28/2014US8871778 Substituted pyrimidine compounds and their use as SYK inhibitors
10/28/2014US8871777 Phenylpyrimidone compounds, the pharmaceutical compositions, preparation methods and uses thereof
10/28/2014US8871775 Compounds
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871746 Antiviral drugs for treatment of arenavirus infection
10/28/2014US8871187 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
10/23/2014US20140316143 Processes for the preparation of novel benzimidazole derivatives
10/23/2014US20140315943 Combination therapy of hsp90 inhibitory compounds with mtor/p13k inhibitors
10/23/2014US20140315913 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/23/2014US20140315887 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/23/2014US20140315886 Quinazolines as therapeutic compounds and related methods of use
10/23/2014US20140315882 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof
10/23/2014US20140315856 Aminopyrazole derivative
10/23/2014US20140315792 Anti-viral compounds
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/21/2014US8865914 Fluorescent probes for detection of copper
10/21/2014US8865912 Benzimidazole derivatives as PI3 kinase inhibitors
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865910 1, 2, 4-triazole derivatives and their anti mycobacterial activity
10/21/2014US8865897 Crystal modifications-3-(1H-indol-3-yl)-4- [4-methyl-piperazin-1-yl)-quinazolin-4-yl] -pyrrole-2, 5-D ione
10/21/2014US8865894 Oxazolidin-2-one compounds and uses thereof
10/21/2014US8865756 Inhibitors of HCV NS5A
10/21/2014US8865755 Dual-acting antihypertensive agents
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865724 Preparation of 2-methyl-4-amino-5(substituted-1H-1,2,3-triazolyl)methylpyrimidine derivatives and microbicidal activity thereof
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8865713 Benzoimidazoles as prolyl hydroxylase inhibitors
10/21/2014US8865711 Phenylimidazole derivatives as PDE10A enzyme inhibitors
10/21/2014US8865704 Wnt pathway antagonists
10/21/2014US8865323 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
10/21/2014US8865122 Methods and compositions for protein labelling
10/16/2014US20140309261 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
10/16/2014US20140309259 Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents
10/16/2014US20140309245 Novel Heterocyclic Carboxamides as Modulators of Kinase Activity
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 626